African governments and global development institutions have launched a continent-wide initiative aimed at reducing reliance on imported medicines and vaccines, a structural vulnerability laid bare during the Covid-19 pandemic.
- •The Africa Initiative for Medical Access and Manufacturing 2030 (AIM2030), unveiled in Nairobi this week, seeks to double local production of key health products while expanding access to affordable medicines and creating skilled jobs across the pharmaceutical value chain.
- •The effort is spearheaded by the World Bank and the African Union Commission, in partnership with national governments, development financiers, and private investors.
- •African countries currently import between 70% and 100% of finished pharmaceutical products and roughly 99% of vaccines, with less than 1% manufactured locally.
This dependence has exposed health systems to supply chain disruptions, export bans, and price volatility during global crises, while long-standing structural constraints ranging from limited production scale to weak regulatory systems hinder domestic industry growth.
AIM2030 targets those bottlenecks by mobilizing capital, aligning policy reforms, and scaling manufacturing capacity across nine countries including Kenya, Egypt, Ethiopia, Ghana, Morocco, Nigeria, Rwanda, Senegal, and South Africa. The initiative also works with regional institutions including the Africa CDC and the emerging Africa Medicines Agency to strengthen regulatory harmonization and market coordination.
The program is structured around three pillars: building foundational infrastructure and workforce capacity; implementing policy and regulatory reforms to improve market efficiency; and crowding in private sector investment through blended finance and partnerships. It is designed to operate through country-level agreements and National Health Compacts under a broader Health Works framework.
Beyond health outcomes, AIM2030 is positioned as an industrial policy lever. Expanding local manufacturing is expected to shorten supply chains, improve availability of priority products, and build resilience against future pandemics.
The launch event in Nairobi brought together senior policymakers and development officials including President William Samoei Ruto, International Finance Corporation Managing Director Makhtar Diop, and World Health Organization Africa Regional Director Mohamed Yakub Janabi.
